Total Payments
$5,882
2024 Payments
$2,955
Companies
34
Transactions
258
Medicare Patients
529
Medicare Billing
$50,765
Payment Breakdown by Category
Food & Beverage$5,882 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,882 | 258 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $987.46 | 32 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $643.10 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $624.63 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $567.29 | 26 | $0 (2024) |
| Novo Nordisk Inc | $535.22 | 27 | $0 (2024) |
| PFIZER INC. | $357.60 | 16 | $0 (2024) |
| Lilly USA, LLC | $285.90 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $219.35 | 14 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $186.26 | 4 | $0 (2024) |
| Amgen Inc. | $160.98 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,955 | 123 | AstraZeneca Pharmaceuticals LP ($413.24) |
| 2023 | $2,069 | 95 | AbbVie Inc. ($433.27) |
| 2022 | $838.18 | 39 | ABBVIE INC. ($211.59) |
| 2019 | $20.46 | 1 | GlaxoSmithKline, LLC. ($20.46) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Bone Health | ||||||
| 12/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $48.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: VACCINE | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.08 | General |
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Endocrinology | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Gastroenterology | ||||||
| 09/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Bone Health | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 483 | 606 | $87,298 | $46,634 |
| 2022 | 2 | 46 | 46 | $7,080 | $4,131 |
Total Patients
529
Total Services
652
Medicare Billing
$50,765
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 229 | 298 | $38,740 | $19,979 | 51.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 192 | $35,520 | $18,898 | 53.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $8,640 | $4,818 | 55.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 23 | $1,610 | $1,578 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $770.00 | $711.04 | 92.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 13 | $390.00 | $382.20 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 22 | $1,628 | $267.74 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 20 | $3,700 | $2,144 | 57.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 26 | $3,380 | $1,987 | 58.8% |
About Dr. Samuel Traverso, DO
Dr. Samuel Traverso, DO is a Family Medicine healthcare provider based in La Grange Highlands, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2019. The National Provider Identifier (NPI) number assigned to this provider is 1902464647.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Traverso, DO has received a total of $5,882 in payments from pharmaceutical and medical device companies, with $2,955 received in 2024. These payments were reported across 258 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,882).
As a Medicare-enrolled provider, Traverso has provided services to 529 Medicare beneficiaries, totaling 652 services with total Medicare billing of $50,765. Data is available for 2 years (2022–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location La Grange Highlands, IL
- Active Since 05/29/2019
- Last Updated 10/10/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902464647
Products in Payments
- VRAYLAR (Drug) $614.86
- TRADJENTA (Drug) $460.95
- JARDIANCE (Drug) $294.27
- FARXIGA (Drug) $287.17
- TRELEGY ELLIPTA (Drug) $275.74
- ELIQUIS (Drug) $230.26
- VOQUEZNA (Drug) $186.26
- AIRSUPRA (Drug) $185.41
- SHINGRIX (Biological) $184.51
- Ozempic (Drug) $153.85
- NURTEC ODT (Drug) $148.31
- MOUNJARO (Drug) $146.95
- Veozah (Drug) $143.53
- UBRELVY (Drug) $141.81
- GVOKE HYPOPEN (Drug) $130.65
- XIFAXAN (Drug) $126.18
- MAVYRET (Drug) $124.45
- Rybelsus (Drug) $106.36
- REXULTI (Drug) $101.77
- QULIPTA (Drug) $91.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in La Grange Highlands
Mr. Daniel Chen, Do, DO
Family Medicine — Payments: $35,420
Family Medicine $35,420
Mr. Scott Robertson, Do, DO
Family Medicine — Payments: $22,311
Family Medicine $22,311
Dr. Michael Dupont, Md, MD
Family Medicine — Payments: $17,604
Family Medicine $17,604
Saba Osmani, Md, MD
Family Medicine — Payments: $340.69
Family Medicine $340.69
Tumendemberel Byambaa, Md, MD
Family Medicine — Payments: $19.76
Family Medicine $19.76
Mr. Chimanbhai Patel, Md, MD
Family Medicine
Family Medicine